We accept all test referrals. Find a Collection Centre

Home Newsroom Leading the way in VWD diagnosis

Leading the way in VWD diagnosis

Media Contact
3rd April, 2023

Dr Emmanuel Favaloro’s passion and expertise lie in bleeding disorder diagnosis and better patient care.

 

Peo­ple with these dis­or­ders bleed exces­sive­ly.  With up to 1% of the world’s pop­u­la­tion poten­tial­ly suf­fer­ing from von Wille­brand dis­ease (VWD) accord­ing to epi­demi­o­log­i­cal stud­ies, it is con­sid­ered by far to be the most com­mon bleed­ing dis­or­der. How­ev­er, since most peo­ple expe­ri­ence very mild symp­toms, it is esti­mat­ed that glob­al­ly as many as 9 out of 10 peo­ple with VWD have not been diagnosed.

 

Dr Faval­oro is a Lab­o­ra­to­ry Sci­en­tist at NSW Health Pathol­o­gy, West­mead ICPMR who spe­cialis­es in lab­o­ra­to­ry test­ing for clot­ting dis­or­ders, includ­ing von Wille­brand dis­ease (VWD).  Accord­ing to a recent study, Emmanuel is the most pro­lif­ic author on von Wille­brand Disease.

 

“When we talk about bleed­ing dis­or­ders, most peo­ple think about Haemophil­ia,” he said.

 

Haemophil­ia A and B are char­ac­terised by a reduc­tion in the func­tion of the pro­teins Fac­tor VIII or Fac­tor IX, which are impor­tant for blood clot­ting. VWD is defined as the lack of or reduced func­tion of a pro­tein called von Wille­brand Fac­tor (VWF) in our blood.

 

VWF has sev­er­al pur­pos­es. Fol­low­ing injury, VWF in your blood plas­ma attach­es to platelets and helps to clump them togeth­er to immo­bilise them. VWF also binds to the injured tis­sue itself to help form a ‘platelet plug’ or ‘platelet clot’ to block the hole and stop bleeding.

 

Peo­ple with VWD either don’t have any VWF, have less VWF or the VWF doesn’t work prop­er­ly, so they con­tin­ue to bleed.

 

Symp­toms can include:

  • Exces­sive bleed­ing from cuts or surgery
  • bleed­ing from the gums dur­ing den­tal work
  • fre­quent nose­bleeds that do not stop with­in 10 minutes
  • heavy or long men­stru­al bleeding
  • heavy bleed­ing dur­ing childbirth
  • blood in urine or stool
  • bruis­ing eas­i­ly or lumpy bruises.

 

Surgery is one of the key con­cerns for peo­ple with VWD because of the increased risk of bleed­ing dur­ing these pro­ce­dures. If a patient has VWD, their health­care team must know in advance so they can pre­pare and man­age any poten­tial bleed­ing. Doc­tors use med­ical his­to­ries to screen patients who may need test­ing for VWD.

 

VWD is hard­er to detect than Haemophil­ia since VWF per­forms sev­er­al roles in our bodies.

 

Emmanuel and his team focus on improv­ing the diag­nos­tic struc­ture for VWD using a pan­el of tests.

 

“We use a vari­ety of func­tion­al tests for a more holis­tic approach to diag­no­sis VWD – a mul­ti-pronged approach.”

 

VWD tests have been around for decades. One of the first tests dates back to the 1960s.

 

“That orig­i­nal test is not in itself a bad test, but it has issues with repro­ducibil­i­ty and low lev­el VWF detec­tion, mak­ing it less accu­rate. If only that test is used, it is pos­si­ble that some peo­ple with VWD will go undi­ag­nosed or else be misdiagnosed.”

 

Today, we use half a dozen dif­fer­ent tests to deter­mine the lev­el and activ­i­ty of VWF. We refer to them as pan­els of tests or assays.

 

“Our NSW Health Pathol­o­gy lab­o­ra­to­ries can inves­ti­gate sev­er­al dif­fer­ent aspects of VWF. To diag­nose VWD, we use sev­er­al tests. Each is designed to check the dif­fer­ent func­tions of VWF.”

 

There are six dif­fer­ent vari­ants of VWD.

 

“Our tests look at how well VWF binds to platelets and a pro­tein (col­la­gen) in dam­aged tis­sue, while anoth­er looks at how well VWF binds to the pro­tein (fac­tor VIII) that is also miss­ing in Haemophil­ia A. Anoth­er test looks at the struc­ture of VWF.

 

“We have a reper­toire of tests avail­able to us. Most of our research aims to improve how we diag­nose bleed­ing dis­eases such as VWD so that clin­i­cians can diag­nose patients, and then man­age them cor­rect­ly. We can also deter­mine which vari­ant of VWD a per­son has.”

 

Cur­rent­ly, there is no genet­ic cure for VWD, but clin­i­cians help patients man­age their symp­toms with var­i­ous therapies.

 

Emmanuel has done a lot of research on diag­nos­tic approach­es for VWD.

 

“I pub­lished my first research on VWD back in 1991. Since then, I’ve pub­lished over 100 papers on the topic.”

 

His work has inter­na­tion­al impli­ca­tions too.

 

“When you look at VWD diag­no­sis around the world, it’s not diag­nosed very well, par­tic­u­lar­ly in devel­op­ing coun­tries where VWD is sig­nif­i­cant­ly underestimated.”

 

Accord­ing to the World Fed­er­a­tion for Haemophil­ia, Aus­tralia iden­ti­fies 100% of patients sus­pect­ed of hav­ing VWD. The USA iden­ti­fies 50–70% of their esti­mat­ed patients with VWD, and iden­ti­fi­ca­tion rates are less than 10% in devel­op­ing countries.

 

Our role in pathol­o­gy is to make sure that we can facil­i­tate the diag­no­sis of every­one with VWD so that clin­i­cians can best man­age their risk of bleeding.

 

And researchers like Emmanuel are vital in this role.

Topics

Skip to content